| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
807,178 | 716,113 | 707,622 | 797,963 | 1,018,878 |
| Cost of Revenue
|
-450,281 | -368,820 | -347,823 | -439,575 | -679,586 |
|
Gross Profit
|
356,897 | 347,293 | 359,799 | 358,388 | 339,292 |
|
Selling, General and Administrative Expenses
|
-40,355 | -42,004 | -48,502 | -40,826 | -41,812 |
| Other Income/Expense, Operating
|
-269,819 | -256,392 | -254,002 | -250,838 | -246,217 |
|
Operating Income/Expenses
|
-310,174 | -298,396 | -302,504 | -291,664 | -288,029 |
|
Total Operating Profit/Loss
|
46,723 | 48,897 | 57,295 | 66,724 | 51,263 |
| Total Net Finance Income/Expense
|
-57,587 | -57,792 | -57,710 | -60,290 | -53,665 |
| Net Investment Income
|
-1,093 | -1,116 | -624 | 0 | 0 |
| Irregular Income/Expenses
|
3,460 | 0 | 0 | -5,121 | 0 |
|
Other Income/Expense, Non-Operating
|
16 | 33 | 25 | 56 | -5 |
|
Non-Operating Income/Expenses, Total
|
-55,204 | -58,875 | -58,309 | -65,355 | -53,670 |
|
Pretax Income
|
-8,476 | -9,973 | -1,010 | 1,369 | -2,407 |
|
Provision for Income Tax
|
-2,676 | -4,772 | -4,197 | -5,918 | -7,927 |
|
Net Income from Continuing Operations
|
-11,152 | -14,745 | -5,207 | -4,549 | -10,334 |
|
Diluted Net Income Available to Common Stockholders
|
-10,885 | -14,389 | -5,078 | -4,444 | -10,087 |
| Net Income Allocated to Limited Partner
|
-10,885 | -14,389 | -5,078 | -4,444 | -10,087 |
|
Net Income Allocated to Common Unitholders
|
-10,885 | -14,389 | -5,078 | -4,444 | -10,087 |
|
Common Dividend per Share
|
0.01 | -- | -- | -- | -- |
| Basic EPS
|
-0.28 | -0.37 | -0.13 | -0.11 | -0.26 |
| Diluted EPS
|
-0.28 | -0.37 | -0.13 | -0.11 | -0.26 |
|
Basic Weighted Average Shares Outstanding
|
38,938.7420 | 38,890.0390 | 38,831.3550 | 38,771.6570 | 38,726.0480 |
|
Diluted Weighted Average Shares Outstanding
|
38,938.7420 | 38,890.0390 | 38,831.3550 | 38,771.6570 | 38,726.0480 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
45,953 | 44,539 | 53,615 | 61,659 | 51,258 |
|
EBITDA
|
97,416 | 94,736 | 104,402 | 111,554 | 107,538 |
|
Normalized EBITDA
|
97,106 | 99,041 | 110,605 | 115,465 | 114,880 |
|
Normalized Income
|
-15,116.1418 | -16,124.1879 | -6,310.6300 | -1,798.3937 | -15,397.1100 |
|
Total Unusual Items
|
-5,326 | -1,853 | -1,397 | 3,911 | -6,409 |
|
Total Unusual Items Excluding Goodwill
|
-5,326 | -1,853 | -1,397 | 3,911 | -6,409 |
12/31/2022 - 11/1/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade